A phase III multicenter study of cytomegalovirus prophylaxis with valacyclovir [valaciclovir] for the prevention of serious fungal and bacterial infections among cytomegalovirus seronegative recipients of cytomegalovirus seropositive sx stem cell transplants

Trial Profile

A phase III multicenter study of cytomegalovirus prophylaxis with valacyclovir [valaciclovir] for the prevention of serious fungal and bacterial infections among cytomegalovirus seronegative recipients of cytomegalovirus seropositive sx stem cell transplants

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Apr 2009

At a glance

  • Drugs Valaciclovir (Primary)
  • Indications Bacterial infections; Cytomegalic inclusion disorders; Cytomegalovirus infections; Mycoses
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top